Rayhan A. Lal, MD

5.0/5

1 Patient Ratings

28 Patient Reviews

Rayhan A. Lal, MD

Endocrinologist

Assistant Professor of Medicine (Endocrinology) and of Pediatrics (Endocrinology)

View Professional Summary

Additional Languages Spoken:

French , Spanish

Insurance Coverage

Resources for Referring Physicians

Biography

I grew up in the east bay area and have had type 1 diabetes for 30+ years. I studied electrical engineering and computer science at U.C. Berkeley (Go Bears!) with the hope of applying my knowledge to diabetes technology. The significance of clinical practice became clear to me after my siblings also developed diabetes. I am devoting my life to advancing the care of diabetes in people of all ages.

View Full Biography

Professional Summary

Education & Certifications

Board Certification: American Board of Pediatrics, Pediatric Endocrinology (2019)
Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism (2018)
Fellowship: Stanford University Endocrinology Fellowship (2019) CA
- Fellowship: Stanford University Pediatric Endocrinology Fellowship (2019) CA
- Board Certification: American Board of Internal Medicine, Internal Medicine (2015)
- Board Certification: American Board of Pediatrics, Pediatrics (2015)
- Residency, Chief Residency, LAC+USC, Internal Medicine & Pediatrics (2015)
- Medical Education: University of California Davis School of Medicine (2011) CA

View More Education & Certifications

Honors & Awards

Alpha Omega Alpha, National medical honor society (2017)
Gold Humanism Honor Society, Gold Foundation (2011)
Outstanding Teaching as a House Officer, University of Southern California (2014)
- Stephen Bechtel Endowed Fellow, Stanford Maternal and Child Health Research Institute (2017-2019)

View More Honors & Awards

Memberships

Consultant, Abbott Diabetes Care (2018 - Present)
Medical Advisory Board, Consultant, Tidepool (2018 - Present)
Medical Advisor, Biolinq (2019 - Present)
- Medical Monitor, Capillary Biomedical (2020 - Present)
- Advisory Board, Provention Bio (2021 - 2021)
- Medical Advisor, Gluroo (2021 - Present)

View More Memberships

Administrative Appointments

Member, Stanford Diabetes Research Center (2020 - Present)

Publications

Amyloid-beta and Glucose Metabolism in Alzheimer's Disease
Furst, A. J., & Lal, R. A. (2011). Amyloid-beta and Glucose Metabolism in Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE, 26, 105–16.
Clinical Use of Continuous Glucose Monitoring in Pediatrics.
Lal, R. A., & Maahs, D. M. (2017). Clinical Use of Continuous Glucose Monitoring in Pediatrics. Diabetes Technology & Therapeutics, 19(S2), S37–S43.
A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID syndrome in a patient with a novel NFKB2 mutation.
Lal, R. A., Bachrach, L. K., Hoffman, A. R., Inlora, J., Rego, S., Snyder, M. P., & Lewis, D. B. (2017). A Case Report of Hypoglycemia and Hypogammaglobulinemia: DAVID syndrome in a patient with a novel NFKB2 mutation. Journal of Clinical Endocrinology and Metabolism.
- A beta Amyloid and Glucose Metabolism in Three Variants of Primary Progressive Aphasia
  Rabinovici, G. D., Jagust, W. J., Furst, A. J., Ogar, J. M., Racine, C. A., Mormino, E. C., … Gorno-Tempini, M. L. (2008). A beta Amyloid and Glucose Metabolism in Three Variants of Primary Progressive Aphasia. ANNALS OF NEUROLOGY, 64(4), 388–401.
- Striatal Dopamine and Working Memory
  Landau, S. M., Lal, R., O'Neil, J. P., Baker, S., & Jagust, W. J. (2009). Striatal Dopamine and Working Memory. CEREBRAL CORTEX, 19(2), 445–54.
- An unusual cause of hyperglycemia
  Lal, R., Loomba-Albrecht, L. A., & Bremer, A. A. (2011). An unusual cause of hyperglycemia. JOURNAL OF POSTGRADUATE MEDICINE, 57(4), 343–46.
- Amyloid-beta and Glucose Metabolism in Alzheimer's Disease
  Furst, A. J., & Lal, R. A. (2011). Amyloid-beta and Glucose Metabolism in Alzheimer's Disease. HANDBOOK OF IMAGING THE ALZHEIMER BRAIN, 2, 235–46.
- Advances in Care for Insulin-Requiring Patients Without Closed Loop.
  Lal, R. A., Buckingham, B., & Maahs, D. M. (2018). Advances in Care for Insulin-Requiring Patients Without Closed Loop. Diabetes Technology & Therapeutics, 20(S2), S285–S291.
- Long-Acting Growth Hormone Preparations in the Treatment of Children.
  Lal, R. A., & Hoffman, A. R. (2018). Long-Acting Growth Hormone Preparations in the Treatment of Children. Pediatric Endocrinology Reviews : PER, 16(Suppl 1), 162–67.
- Diabetes Technology and Therapy in the Pediatric Age Group.
  Maahs, D. M., Lal, R., & Shalitin, S. (2019). Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes Technology & Therapeutics, 21(S1), S123–S137.
- Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
  Lal, R. A., Ekhlaspour, L., Hood, K., & Buckingham, B. (2019). Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes. Endocrine Reviews.
- Optimizing Basal Insulin Dosing.
  Lal, R. A., & Maahs, D. M. (2019). Optimizing Basal Insulin Dosing. The Journal of Pediatrics.
- Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum
  Sang, A. X., Lal, R., August, A., Danzer, E., Buckingham, B., & Mueller, C. M. (2019). Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum. CLINICAL CASE REPORTS.
- Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum.
  Sang, A. X., Lal, R., August, A., Danzer, E., Buckingham, B., & Mueller, C. M. (2019). Fluoroscopic-assisted laparoscopic retrieval of retained glucose sensor wire from the omentum. Clinical Case Reports, 7(9), 1717–1720.
- One Year Clinical Experience of the First Commercial Hybrid Closed-Loop.
  Lal, R. A., Basina, M., Maahs, D. M., Hood, K., Buckingham, B., & Wilson, D. M. (2019). One Year Clinical Experience of the First Commercial Hybrid Closed-Loop. Diabetes Care.
- Suicide and Self-inflicted Injury in Diabetes: A Balancing Act.
  Barnard-Kelly, K. D., Naranjo, D., Majidi, S., Akturk, H. K., Breton, M., Courtet, P., … Renard, E. (2019). Suicide and Self-inflicted Injury in Diabetes: A Balancing Act. Journal of Diabetes Science and Technology, 1932296819891136.
- Perspectives on long-acting growth hormone therapy in children and adults.
  Lal, R. A., & Hoffman, A. R. (2019). Perspectives on long-acting growth hormone therapy in children and adults. Archives of Endocrinology and Metabolism, 63(6), 601–7.
- THE GUIDED TRANSFER OF CARE IMPROVES ADULT CLINIC SHOW RATE.
  Lal, R. A., Maahs, D. M., Dosiou, C., Aye, T., & Basina, M. (2020). THE GUIDED TRANSFER OF CARE IMPROVES ADULT CLINIC SHOW RATE. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
- Insulin Pumps.
  Lal, R., & Leelarathna, L. (2020). Insulin Pumps. Diabetes Technology & Therapeutics, 22(S1), S17–S31.
- Postmenopausal Hyperandrogenism.
  Lal, R. A., & Basina, M. (2018). Postmenopausal Hyperandrogenism. Journal of Women's Health Care, 7(1).
- Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care.
  Lal, R. A., Cuttriss, N., Haller, M. J., Yabut, K., Anez-Zabala, C., Hood, K. K., … Walker, A. F. (2020). Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care. Clinical Diabetes : a Publication of the American Diabetes Association, 38(2), 159–65.
- An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes.
  Barnard-Kelly, K. D., Naranjo, D., Majidi, S., Akturk, H. K., Breton, M., Courtet, P., … Renard, E. (2020). An Intolerable Burden: Suicide, Intended Self-Injury and Diabetes. Canadian Journal of Diabetes.
- Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System.
  Hsu, L. J., Buckingham, B. A., Basina, M., Ekhlaspour, L., von Eyben, R., Wang, J., & Lal, R. A. (2020). Fast-Acting Insulin Aspart Use with the MiniMed™ 670G System. Diabetes Technology & Therapeutics.
- A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
  Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., … Wadwa, R. P. (2020). A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. The New England Journal of Medicine, 383(9), 836–45.
- A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System.
  Lum, J., Bailey, R., Barnes-Lomen, V., Naranjo, D., Hood, K., Lal, R. A., … Beck, R. W. (2020). A Real-World Prospective Study of the Safety and Effectiveness of the Loop Open Source Automated Insulin Delivery System. Diabetes Technology & Therapeutics.
- Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control.
  Cobry, E., Kanapka, L., Cengiz, E., Carria, L., Ekhlaspour, L., Buckingham, B. A., … Wadwa, R. P. (2021). Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technology & Therapeutics.
- Engineering biopharmaceutical formulations to improve diabetes management.
  Maikawa, C. L., d'Aquino, A. I., Lal, R. A., Buckingham, B. A., & Appel, E. A. (2021). Engineering biopharmaceutical formulations to improve diabetes management. Science Translational Medicine, 13(578).
- Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System.
  Schoelwer, M. J., Kanapka, L. G., Wadwa, R. P., Breton, M. D., Ruedy, K. J., Ekhlaspour, L., … DeBoer, M. D. (2021). Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technology & Therapeutics.
- Feasibility of Spotlight Consultations Tool in Routine Care: Real-World Evidence.
  Barnard-Kelly, K., Kelly, R. C., Chernavvsky, D., Lal, R., Cohen, L., & Ali, A. (2021). Feasibility of Spotlight Consultations Tool in Routine Care: Real-World Evidence. Journal of Diabetes Science and Technology, 1932296821994088.
- Longevity of the Novel ConvaTec Infusion Set with Lantern Technology.
  Lal, R. A., Hsu, L., Zhang, J., Schondorff, P. K., Heschel, M., & Buckingham, B. (2021). Longevity of the Novel ConvaTec Infusion Set with Lantern Technology. Diabetes, Obesity & Metabolism.
- Full closed loop open-source algorithm performance comparison in pigs with diabetes.
  Lal, R. A., Maikawa, C. L., Lewis, D., Baker, S. W., Smith, A. A., Roth, G. A., … Appel, E. A. (2021). Full closed loop open-source algorithm performance comparison in pigs with diabetes. Clinical and Translational Medicine, 11(4), e387.
- Insulin Delivery Hardware: Pumps and Pens.
  Lal, R. A., & Leelarathna, L. (2021). Insulin Delivery Hardware: Pumps and Pens. Diabetes Technology & Therapeutics, 23(S2), S32–S45.
- Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D.
  Walker, A. F., Cuttriss, N., Haller, M. J., Hood, K. K., Gurka, M. J., Filipp, S. L., … Maahs, D. M. (2021). Democratizing type 1 diabetes specialty care in the primary care setting to reduce health disparities: project extension for community healthcare outcomes (ECHO) T1D. BMJ Open Diabetes Research & Care, 9(1).
- Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
  Maikawa, C. L., Chen, P. C., Vuong, E. T., Nguyen, L. T., Mann, J. L., d'Aquino, A. I., … Appel, E. A. (2021). Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), e2101575.
- Automated Insulin Dosing Systems: Advances After a Century of Insulin.
  Thabit, H., Lal, R., & Leelarathna, L. (2021). Automated Insulin Dosing Systems: Advances After a Century of Insulin. Diabetic Medicine : a Journal of the British Diabetic Association, e14695.
- Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study.
  Forlenza, G. P., Vigers, T., Berget, C., Messer, L., Lal, R. A., Basina, M., … Pyle, L. (2021). Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study. Diabetes Technology & Therapeutics.
- Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation.
  Wong, J., Suttiratana, S., Lal, R. A., Lum, J., Lanning, M. S., Dunlap, A., … Naranjo, D. (2021). Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation. Diabetes Technology & Therapeutics.
- Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.
  Braune, K., Lal, R. A., Petruzelkova, L., Scheiner, G., Winterdijk, P., Schmidt, S., … Hussain, S. (2021). Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. The Lancet. Diabetes & Endocrinology.
- Novel Pathogenic de novo INS p.T97P Variant Presenting with Severe Neonatal DKA.
  Lal, R. A., Moeller, H. P., Thomson, E. A., Horton, T. M., Lee, S., Freeman, R., … Annes, J. P. (2021). Novel Pathogenic de novo INS p.T97P Variant Presenting with Severe Neonatal DKA. Endocrinology.
- Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery (AID) System.
  Suttiratana, S., Wong, J., Lanning, M. S., Dunlap, A. R., Hanes, S., Hood, K., … Naranjo, D. (1800). Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery (AID) System. Diabetes Technology & Therapeutics.
- Current Status and Emerging Options for Automated Insulin Delivery Systems.
  Forlenza, G. P., & Lal, R. A. (1800). Current Status and Emerging Options for Automated Insulin Delivery Systems. Diabetes Technology & Therapeutics.
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
  Klonoff, D. C., Wang, J., Rodbard, D., Kohn, M. A., Li, C., Liepmann, D., … Kovatchev, B. (2022). A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of Diabetes Science and Technology, 19322968221085273.
- Insulin Delivery Hardware: Pumps and Pens.
  Lal, R., & Leelarathna, L. (2022). Insulin Delivery Hardware: Pumps and Pens. Diabetes Technology & Therapeutics, 24(S1), S21–S34.
- Smartwatch Gesture-Based Meal Reminders Improve Glycemic Control.
  Corbett, J. P., Hsu, L., Brown, S. A., Kollar, L., Vleugels, K., Buckingham, B., … Lal, R. A. (2022). Smartwatch Gesture-Based Meal Reminders Improve Glycemic Control. Diabetes, Obesity & Metabolism.
- Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System.
  Wong, J. J., Hood, K. K., Hanes, S. J., Lal, R. A., & Naranjo, D. (2022). Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System. Journal of Diabetes Science and Technology, 19322968221105288.
- Temporal changes in hemoglobin A1c and diabetes technology use in DPV, NPDA and T1DX pediatric cohorts from 2010 to 2018.
  Lal, R. A., Robinson, H., Lanzinger, S., Miller, K., Perez, S. P., Kovacic, R., … Warner, J. (2022). Temporal changes in hemoglobin A1c and diabetes technology use in DPV, NPDA and T1DX pediatric cohorts from 2010 to 2018. Diabetes Technology & Therapeutics.
- Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice.
  Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., … Battelino, T. (2022). Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocrine Reviews.
- Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in Federally Qualified Health Centers.
  Walker, A. F., Addala, A., Sheehan, E., Lal, R., Haller, M., Cuttriss, N., … Maahs, D. (2022). Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in Federally Qualified Health Centers. Diabetes Spectrum : a Publication of the American Diabetes Association, 35(3), 295–303.
- Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
  Russell, S. J., Beck, R. W., Damiano, E. R., El-Khatib, F. H., Ruedy, K. J., Balliro, C. A., … Dauber, A. (2022). Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. The New England Journal of Medicine, 387(13), 1161–1172.
- Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society.
  Vimalananda, V. G., Brito, J. P., Eiland, L. A., Lal, R. A., Maraka, S., McDonnell, M. E., … Crossen, S. S. (2022). Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society. The Journal of Clinical Endocrinology and Metabolism.
- Open-source automated insulin delivery in type 1 diabetes-the evidence is out there.
  Hussain, S., Lal, R. A., & Braune, K. (2022). Open-source automated insulin delivery in type 1 diabetes-the evidence is out there. The Lancet. Diabetes & Endocrinology.
- Tele-education model for primary care providers to advance diabetes equity: Findings from Project ECHO Diabetes.
  Addala, A., Filipp, S. L., Figg, L. E., Anez-Zabala, C., Lal, R. A., Gurka, M. J., … Walker, A. F. (2022). Tele-education model for primary care providers to advance diabetes equity: Findings from Project ECHO Diabetes. Frontiers in Endocrinology, 13, 1066521.
- Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings.
  Lewit, E. M., Figg, L. E., Addala, A., Filipp, S. L., Lal, R., Gurka, M. J., … Walker, A. F. (2023). Project ECHO Diabetes Cost Modeling to Support the Replication and Expansion of Tele-mentoring Programs in Non-research Settings. Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders.
- Diabetes Technology Meeting 2022.
  Huang, J., Yeung, A. M., DuBord, A. Y., Wolpert, H., Jacobs, P. G., Lee, W.-A. A., … Klonoff, D. C. (2023). Diabetes Technology Meeting 2022. Journal of Diabetes Science and Technology, 19322968221148743.
- Insulin Delivery Hardware: Pumps and Pens.
  Lal, R. A., & Leelarathna, L. (2023). Insulin Delivery Hardware: Pumps and Pens. Diabetes Technology & Therapeutics, 25(S1), S30–S43.
- Frequency and detection of insulin infusion site failure in the Type 1 Diabetes Exchange Online Community.
  Hughes, M. S., Douvas, J. L., Layfield-Bryan, M., Blanco, L. E., Gray, J. C., Zapotoczny, G., … Lal, R. A. (2023). Frequency and detection of insulin infusion site failure in the Type 1 Diabetes Exchange Online Community. Diabetes Technology & Therapeutics.
- The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm.
  Braune, K., Hussain, S., & Lal, R. (2023). The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm. Journal of Diabetes Science and Technology, 19322968231164166.
- Spectro-spatial features in distributed human intracranial activity proactively encode peripheral metabolic activity.
  Huang, Y., Wang, J. B., Parker, J. J., Shivacharan, R., Lal, R. A., & Halpern, C. H. (2023). Spectro-spatial features in distributed human intracranial activity proactively encode peripheral metabolic activity. Nature Communications, 14(1), 2729.
- Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes.
  Zaharieva, D. P., Morrison, D., Paldus, B., Lal, R. A., Buckingham, B. A., & O'Neal, D. N. (2023). Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes. Diabetes Spectrum : a Publication of the American Diabetes Association, 36(2), 127–136.
- Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water.
  Hughes, M. S., Kingman, R. S., Hsu, L., Lal, R. A., Buckingham, B. A., & Zaharieva, D. P. (2023). Swimming With the Omnipod 5 Automated Insulin Delivery System: Connectivity in the Water. Diabetes Care.
- The Promising Success of Project Extension for Community Healthcare Outcomes (ECHO) Diabetes: Case Series.
  Figg, L., Addala, A., Jain, I., Anez, C., Midney, P., DeChirico, C., … Lal, R. A. (2023). The Promising Success of Project Extension for Community Healthcare Outcomes (ECHO) Diabetes: Case Series. JMIR Diabetes, 8, e46050.
- Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multi-Center, Single-arm, Feasibility Trial.
  Davis, G. M., Hughes, M. S., Brown, S., Sibayan, J., Perez-Guzman, M. C., Stumpf, M., … Pasquel, F. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multi-Center, Single-arm, Feasibility Trial. Diabetes Technology & Therapeutics.
- Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA.
  Addala, A., Hechavarria, M., Figg, L., Roque, X., Filipp, S. L., Anez-Zabala, C., … Walker, A. F. (2023). Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA. BMJ Open, 13(8), e072546.
- Multisite Quality Improvement Program Within the Project ECHO Diabetes Remote Network.
  Wang, C. J., Lewit, E. M., Clark, C. L., Lee, F.-S. W., Maahs, D. M., Haller, M. J., … Walker, A. F. (2023). Multisite Quality Improvement Program Within the Project ECHO Diabetes Remote Network. Joint Commission Journal on Quality and Patient Safety.
- Breaking a feedback loop: A reassessment of an investigator initiated OS-AID study.
  Braune, K., Hussain, S., Lal, R., Leibrand, S., Lewis, D. M., & O'Donnell, S. (2023). Breaking a feedback loop: A reassessment of an investigator initiated OS-AID study. Diabetes, Obesity & Metabolism.
- Following in Banting's footsteps or straying from the path? Observations from contemporary diabetes innovation.
  Leadley, C., Addala, A., Berkeley, J., Crocket, H., Davis, E. A., Hewapathirana, N., … Burckhardt, M.-A. A. (2023). Following in Banting's footsteps or straying from the path? Observations from contemporary diabetes innovation. Frontiers in Endocrinology, 14, 1270517.
- A cysteine-specific solubilizing tag strategy enables efficient chemical protein synthesis of difficult targets
  Li, W., Jacobsen, M. T., Park, C., Jung, J. U., Lin, N.-P., Huang, P.-S., … Chou, D. H.-C. (2024). A cysteine-specific solubilizing tag strategy enables efficient chemical protein synthesis of difficult targets. CHEMICAL SCIENCE.
- Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes.
  Bauza, C., Kanapka, L. G., Greene, E., Lal, R. A., Arbiter, B., & Beck, R. W. (2024). Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes. Diabetes Technology & Therapeutics.
- A cysteine-specific solubilizing tag strategy enables efficient chemical protein synthesis of difficult targets.
  Li, W., Jacobsen, M. T., Park, C., Jung, J. U., Lin, N.-P. P., Huang, P.-S. S., … Chou, D. H.-C. (2024). A cysteine-specific solubilizing tag strategy enables efficient chemical protein synthesis of difficult targets. Chemical Science, 15(9), 3214–3222.
- Insulin Delivery Hardware: Pumps and Pens.
  Lal, R., & Leelarathna, L. (2024). Insulin Delivery Hardware: Pumps and Pens. Diabetes Technology & Therapeutics, 26(S1), S32–S44.
- COVID-19 impacts and inequities among underserved communities with diabetes.
  Maizel, J. L., Haller, M. J., Maahs, D. M., Addala, A., Lal, R. A., Filipp, S. L., … Walker, A. F. (2024). COVID-19 impacts and inequities among underserved communities with diabetes. Journal of Clinical & Translational Endocrinology, 36, 100337.
- Development of a Real-time Force-based Algorithm for Infusion Failure Detection.
  Blanco, L. E., Wilcox, J. H., Hughes, M. S., & Lal, R. A. (2024). Development of a Real-time Force-based Algorithm for Infusion Failure Detection. Journal of Diabetes Science and Technology, 19322968241247530.
- Multicenter Evaluation of Ultra-Rapid Lispro (URLi) Insulin with Control-IQ Technology in Adults, Adolescents and Children with Type 1 Diabetes.
  Levy, C., Bailey, R., Laffel, L. M., Forlenza, G. P., DiMeglio, L. A., Hughes, M. S., … Beck, R. W. (2024). Multicenter Evaluation of Ultra-Rapid Lispro (URLi) Insulin with Control-IQ Technology in Adults, Adolescents and Children with Type 1 Diabetes. Diabetes Technology & Therapeutics.
- Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.
  Lee, M. Y., Seav, S. M., Ongwela, L., Lee, J. J., Aubyrn, R., Cao, F. Y., … Hughes, M. S. (2024). Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin. Diabetes Care.
- Refining Insulin on Board with netIOB for Automated Insulin Delivery.
  Riddell, M. C., Lewis, D. M., Turner, L. V., Lal, R. A., Shahid, A., & Zaharieva, D. P. (2024). Refining Insulin on Board with netIOB for Automated Insulin Delivery. Journal of Diabetes Science and Technology, 19322968241267820.
- Project Extension for Community Healthcare Outcomes Intervention Evaluations: A Scoping Review of Research Methods.
  Maizel, J., Filipp, S. L., Zori, G., Yadav, S., Avaiya, K., Figg, L., … Walker, A. F. (2024). Project Extension for Community Healthcare Outcomes Intervention Evaluations: A Scoping Review of Research Methods. The Journal of Continuing Education in the Health Professions.
- Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts.
  Walker, A. F., Haller, M. J., Addala, A., Filipp, S. L., Lal, R., Gurka, M. J., … Maahs, D. M. (2024). Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts. BMJ Open Diabetes Research & Care, 12(4).
- The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
  Klonoff, D. C., Freckmann, G., Pleus, S., Kovatchev, B. P., Kerr, D., Tse, C. C., … Kohn, M. A. (2024). The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors. Journal of Diabetes Science and Technology, 19322968241275701.
- Perspectives on Artificial Intelligence-Generated Responses to Patient Messages.
  Kim, J., Chen, M. L., Rezaei, S. J., Liang, A. S., Seav, S. M., Onyeka, S., … Linos, E. (2024). Perspectives on Artificial Intelligence-Generated Responses to Patient Messages. JAMA Network Open, 7(10), e2438535.
- Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial.
  Renard, E., Weinstock, R. S., Aleppo, G., Bode, B. W., Brown, S. A., Castorino, K., … Ly, T. T. (2024). Efficacy and Safety of a Tubeless AID System Compared With Pump Therapy With CGM in the Treatment of Type 1 Diabetes in Adults With Suboptimal Glycemia: A Randomized, Parallel-Group Clinical Trial. Diabetes Care.
- Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.
  Shah, V. N., Peters, A. L., Umpierrez, G. E., Sherr, J. L., Akturk, H. K., Aleppo, G., … Klonoff, D. C. (2024). Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System. Journal of Diabetes Science and Technology, 19322968241291512.
- Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care.
  Hughes, M. S., Pasquel, F. J., Davis, G. M., Lal, R. A., Buckingham, B. A., Boughton, C. K., … Bally, L. (2024). Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care. Diabetes Technology & Therapeutics.
- Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People.
  Walker, A. F., Haller, M. J., Addala, A., Filipp, S. L., Lal, R. A., Gurka, M. J., … Maahs, D. M. (2024). Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People. Diabetes Care.
- Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies
  Saef, J., Scandinaro, A., Montgomery, R., Sundaravel, S., Weinreb, S., Dodeja, A., … Roth, T. S. (2024). Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies. CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 27(1).
- Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.
  Thomson, E. A., Lee, S., Xu, H., Moeller, H., Sands, J., Lal, R. A., … Poon, A. S. (2025). Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics. Diabetes.
- Insulin Delivery Hardware: Pumps and Pens.
  Lal, R., & Leelarathna, L. (2025). Insulin Delivery Hardware: Pumps and Pens. Diabetes Technology & Therapeutics, 27(S1), S31–S40.
- CHANGE IN A1C AND CGM USE AFTER PROJECT ECHO IMPLEMENTATION IN US FEDERALLY QUALIFIED HEALTH CENTERS (FQHC)
  Walker, A., Haller, M., Filipp, S., Figg, L., Gurka, M., Addala, A., … Maahs, D. (2024). CHANGE IN A1C AND CGM USE AFTER PROJECT ECHO IMPLEMENTATION IN US FEDERALLY QUALIFIED HEALTH CENTERS (FQHC). DIABETES TECHNOLOGY & THERAPEUTICS. MARY ANN LIEBERT, INC.
- PERFORMANCE EVALUATION OF AUTOMATED INSULIN DELIVERY SYSTEMS ON A PREGNANCY SPECIFIC TYPE 1 DIABETES SIMULATOR
  Banerjee, A., Kudva, Y., Levy, C., Kaur, R. J., Polsky, S., Lal, R., … Gupta, S. (2024). PERFORMANCE EVALUATION OF AUTOMATED INSULIN DELIVERY SYSTEMS ON A PREGNANCY SPECIFIC TYPE 1 DIABETES SIMULATOR. DIABETES TECHNOLOGY & THERAPEUTICS. MARY ANN LIEBERT, INC.
- HIGH SATISFACTION WITH CONTROL-IQ 1.5 AND LYUMJEV INSULIN IN CHILDREN, ADOLESCENTS AND ADULTS WITH TYPE 1 DIABETES
  Levy, C., Bailey, R., Laffel, L., Forlenza, G., Dimeglio, L., Lal, R., … Pollom, R. K. (2024). HIGH SATISFACTION WITH CONTROL-IQ 1.5 AND LYUMJEV INSULIN IN CHILDREN, ADOLESCENTS AND ADULTS WITH TYPE 1 DIABETES. DIABETES TECHNOLOGY & THERAPEUTICS. MARY ANN LIEBERT, INC.
- REAL-WORLD GLYCEMIC OUTCOMES OF > 47,700 ADULTS WITH TYPE 1 DIABETES USING THE OMNIPOD® 5 AUTOMATED INSULIN DELIVERY (AID) SYSTEM WITH CLOUD-BASED DATA MANAGEMENT
  Gibb, F., Lal, R., Aleppo, G., Huyett, L., Mendez, J., Hadjiyianni, I., & Ly, T. (2024). REAL-WORLD GLYCEMIC OUTCOMES OF > 47,700 ADULTS WITH TYPE 1 DIABETES USING THE OMNIPOD® 5 AUTOMATED INSULIN DELIVERY (AID) SYSTEM WITH CLOUD-BASED DATA MANAGEMENT. DIABETES TECHNOLOGY & THERAPEUTICS. MARY ANN LIEBERT, INC.
- EFFICACY AND SAFETY OF THE AUTOMATED OMNIPOD® 5 SYSTEM COMPARED TO INSULIN PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED, CONTROLLED TRIAL
  Renard, E., Weinstock, R., Aleppo, G., Bode, B., Brown, S., Castorino, K., … Ly, T. (2024). EFFICACY AND SAFETY OF THE AUTOMATED OMNIPOD® 5 SYSTEM COMPARED TO INSULIN PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES: A RANDOMIZED, CONTROLLED TRIAL. DIABETES TECHNOLOGY & THERAPEUTICS. MARY ANN LIEBERT, INC.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Specializing In

Diabetes and High Blood Pressure

Practice Locations

Endocrinology Clinic at Boswell Building Palo Alto, CA

Palo Alto, CA

Endocrinology Clinic at Boswell Building

300 Pasteur Dr, Fl 1 Ste A175

Palo Alto , CA 94305

(650) 721-1300

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(1 Ratings)

Overall Rating

5.0/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(28 reviews)

Outstanding provider

Dec 2024

•

Verified SHC Patient

He is the best! I appreciate all his help and care. Thank you.

Nov 2024

•

Verified SHC Patient

Excellent doctor

Apr 2024

•

Verified SHC Patient

Excellent physician

Apr 2024

•

Verified SHC Patient

Outstanding physician. Competent and very good listener.

Feb 2024

•

Verified SHC Patient

Outstanding physician. Excellent listening skills. Highly knowledgeable.

Oct 2023

•

Verified SHC Patient

Dr Lal is the most wonderful doctor I have ever had! He takes time to listen in detail, understands that every patient is unique, and considers alternative medical plans to take the best care of me. I feel so lucky!!

Sep 2023

•

Verified SHC Patient

He's awesome.

Jul 2023

•

Verified SHC Patient

He is so kind and caring. I feel he is interested me as a whole person not just with a disease I appreciate his sense of humor and positive attitude.. one of the most caring doctors I have met

Jun 2023

•

Verified SHC Patient

Great!

Jun 2023

•

Verified SHC Patient

I feel so good that I can stay with my son's endocrinologist from Stanford even though we moved so far away. There are no Endocrinologists within 100 miles of us. Dr. Lal makes us feel like help is just next door! Very comforting for a mom!

Jun 2023

•

Verified SHC Patient

Dr. Lal is a pleasure to talk to and always makes me feel very well cared for. He's the best doctor I've had in the 17 years I've had diabetes.

Apr 2023

•

Verified SHC Patient

Dr. Lal is an exceptional physician. He displays compassion when talking to me about my diabetes and explains both sides of clinical options. He makes time to ask me about any concerns that I might have. When changing care plans, he also prepares me for potential side effects or how to measure effectiveness. I feel very, very lucky to have Dr. Lal as my physician!

Mar 2023

•

Verified SHC Patient

Dr. Lal is absolutely wonderful!

Oct 2022

•

Verified SHC Patient

Dr Lal is incredible!

Aug 2022

•

Verified SHC Patient

He is very caring and never makes me feel like I failed. He is very informative and explains everything. He makes me feel like I have a voice. I hope he never transfers.

Feb 2022

•

Verified SHC Patient

Rayhan Lal is an incredible doctor and endocrinologist. I recommend him to anyone wanting the most advanced care for type 1 diabetes.

Feb 2022

•

Verified SHC Patient

Dr. Lal is an excellent and listens to the patient and has good communication skills and he is very caring.

Jan 2022

•

Verified SHC Patient

He is great!

Jan 2022

•

Verified SHC Patient

Excellent doctor, I enjoy talking with him, and we get through everything concerning my diabetes care.

Jan 2022

•

Verified SHC Patient

He is caring. I feel valued in both listening to me and my questions and concerns. He is clear in his explanations. I appreciate his interest in me as a person not just a case. I appreciated him sharing himself as a person. I look forward to working with him in the future. You are lucky to have him.

Dec 2021

•

Verified SHC Patient

He is an outstanding Doctor, with excellent communication skills. He explained clearly my medical condition thoroughly and he reviewed my recent exams. Along with giving me options to choose from after the surgery. Thank you Doc Rayhan Lal.

Nov 2021

•

Verified SHC Patient

Dr. Rayhan Lal is incredible!!!! Both personable and extraordinarily knowledgeable. Seriously the best doctor I have ever worked with in my fairly long life with many wonderful doctors.

Sep 2021

•

Verified SHC Patient

Excellent doctor, I really look forward to having his help treating my diabetes.

Aug 2021

•

Verified SHC Patient

Dr Lal is a great partner and advisor in my healthcare.

Aug 2021

•

Verified SHC Patient

Excellent physician. Well informed and empathetic. Clearly delivers information. Asks clear and pertinent questions. Top 1% of docs!

Jul 2021

•

Verified SHC Patient

There is no better doctor in all the world. He knows The technical and medical aspects extraordinarily well. And I know that he actually cares about me as a person. This is very rare, and amazing.

Jun 2021

•

Verified SHC Patient

Dr Lal is brilliant. Full Stop!

May 2021

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Rayhan A. Lal, MD

Endocrinologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Endocrinology Clinic at Boswell Building Palo Alto, CA

Endocrinology Clinic at Boswell Building

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(28 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Rayhan A. Lal, MD

Endocrinologist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Endocrinology Clinic at Boswell Building Palo Alto, CA

Endocrinology Clinic at Boswell Building

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(28 reviews)

Referring Physicians

PHYSICIAN HELPLINE